← Back to feedRead original →
VERIFIEDET Finance·neutral
Lupin arm to commercialise YUVEZZI eye drop across key European markets
AI Summary
- ·Lupin's VISUfarma BV has obtained exclusive rights for the YUVEZZI eye drop in major European markets.
- ·YUVEZZI is an ophthalmic product designed to treat loss of clear close-up vision in adults.
- ·VISUfarma will manage regulatory processes and the commercial launch of the eye drop.